Correction, focus and drive is critical for the Company. Holders are just here, for what ever ride, good or bad there is.
In the end this ann while nice is not a driver as we already have trials that are or are not underway, that are or are not completed and that may or may not progress. This does build on a potential body of work but we are a long way off.
I for one just hope on Covid or MnD to provide a shorter time frame shot in the arm to the SP. As I think the cancer market veterinarian or otherwise is still a long way off being a driver for us.
If there was another Elanco really sitting in the wings with baited breath waiting to swoop we would have that news by now. Yes I know that they are talking with VET majors etc but again that just means hey guys we may have something here. I speak to many pharma's when I go to the chemist too....(probably too cheeky a dig)
In any case as usual with PAA the SP talks and this one said minor interest on miniscule amounts but not a driver.
- Forums
- ASX - By Stock
- NUZ
- Ann: PharmAust Expands Lymphoma Canine Trial to the USA
Ann: PharmAust Expands Lymphoma Canine Trial to the USA, page-24
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
18.5¢ |
Change
-0.015(7.50%) |
Mkt cap ! $95.88M |
Open | High | Low | Value | Volume |
20.0¢ | 20.5¢ | 18.5¢ | $106.2K | 550.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 714303 | 18.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.0¢ | 26750 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 714303 | 0.185 |
8 | 384080 | 0.180 |
5 | 151797 | 0.175 |
7 | 208030 | 0.170 |
1 | 60000 | 0.165 |
Price($) | Vol. | No. |
---|---|---|
0.190 | 26750 | 1 |
0.195 | 108645 | 5 |
0.205 | 106604 | 5 |
0.210 | 148876 | 3 |
0.215 | 154400 | 2 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online